Regen Biopharma, Inc.Regen Biopharma, Inc.Regen Biopharma, Inc.

Regen Biopharma, Inc.

No trades
See on Supercharts

RGBP fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Regen Biopharma, Inc. is a biotechnology company, which engages in the business of developing regenerative medical applications and advancing novel technologies through pre-clinical and Phase I and II clinical trials. It also focuses on mRNA and small molecule therapies for treating cancer and autoimmune disorders. The company was founded on April 24, 2012 and is headquartered in La Mesa, CA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
RGBP has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company